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Abstract
Transcranial magnetic stimulation (TMS) has been regarded as a novel technique of neuromodulation
with applications that span from the treatment of depression or depression related symptoms to the
mapping of cerebral regions. This review takes an in depth look into the different forms of magnetic
stimulation including repetitive TMS, theta-burst stimulation, and navigated TMS. The efficacy of these
different forms of stimulation is addressed as well as comparisons made to current standards being used.
Potential clinically relevant future applications of TMS are also discussed from the treatment of obsessive
compulsive disorder to improving motor function after stroke. The purpose of this review is to provide the
background information needed to better understand the constructive benefits of TMS and provide
evidence for why it has a viable future in clinical settings.
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TRANSCRANIAL MAGNETIC
STIMULATION:
Introduction
With advances in technology, surgical
procedures are becoming more automated and
pharmaceuticals are increasing in effectiveness
and specificity. The changing mentality of
generations opting for more holistic and noninvasive treatments is putting pressure on the
medical industry to be innovative and creative in
finding new ways to go about treating diseases
and disorders [1-4]. There is also a push from
the medical industry for more well-developed,
minimally invasive procedures. This focus is on
decreasing the length of stay for patients as well
as costs [5-7]. One form of treatment that is
gaining attention is transcranial magnetic
stimulation (TMS). A neuro-modularly method
of exciting or inhibiting neuronal function with
magnetic waves within the brain to elicit
specific, intended results.

way in the past decades, with the initial
development being for furthering our
understanding of how the brain functions [10], it
has since, expanded to new ways of treating
diseases previously thought to only be
manageable by medications [11].
Two coils are oriented in a figure of
eight fashion connected to a power source via a
handle. A transformer charges a capacitor which
can instantly discharge. Instantaneous discharge
generates electrical currents flowing through the
coils in opposing directions of one another. The
opposing electrical fields generate magnetic
fields that last for fractions of a second. The
magnetic fields that are then applied over the
scalp (figure 1), overlying the cortical area of
interest where neuronal synapses are altered,
either depressing or exciting cortical excitability
depending on the frequency [10, 12].

How it Works
There are numerous forms of
neuromodulation but TMS differs from
transcranial electric stimulation, another form of
neuromodulation. While transcranial electric
stimulation excites pyramidal tracts of neurons
directly, TMS excites neurons trans-synaptically
[8]. This means that the neuromodulation
occurring from TMS is happening in the
synaptic cleft between neurons, affecting
neurotransmitter release.

Figure 1. Simple diagram of how Transcranial
Magnetic Stimulation works. A source of power (A)
charges the capacitors (B). The capacitors are then
able to send pulses of electrical current through the
coils (C). The coils rest on the scalp (D) and the
underlying cortical region is targeted (E) [12].

TMS utilizes magnetic fields produced
via currents running through coils in either a
circular or a figure of eight pattern. These
magnetic fields can induce cortical modulation
through excitation or depression of neurons
below the application site. Being a non-invasive
procedure, it is gaining popularity as an
alternative to current pharmaceutical or invasive
forms of treatment. It has clinical applications
ranging from treatment of depression to corticobrain mapping with new applications being
tested and refined [9]. TMS has come a long

Generally, TMS, is very well tolerated
with reports of minor discomfort at the site of
application during treatment being most
commonly reported [13]. For patients, treatment
requires nothing beyond their presence and
patience while the clinician, which can be a
doctor, psychiatrist, physiologist, nurse
practitioner, or physician assistant with suitable
training and certification, applies the magnetic
field to the intended region of the brain. Patients
can read, converse, or even nap during
treatment. The most common and widely
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accepted use of TMS is in the treatment of
depression and/or depression related symptoms
[10]. A course of treatment for depression
entails sessions lasting roughly 30-40 minutes,
can range from 3-6 times a week and span for
three to six weeks. TMS has been found to be
especially useful in patients who have had failed
results from previous pharmaceutical
intervention [14].
Depending on the desired effects of
treatment, neurons can either be excited or
depressed by TMS. The focus is to promote
neuro-modulation in the region of the brain that
is associated with the symptoms presented. In
other applications, TMS is being used to depress
overexcited neurons that can lead to disorders
such as epilepsy or obsessive-compulsive
disorder (OCD).
Signals originating from the upper
regions of the cerebrum start in cortical regions
and spread the signal via action potentials down
axons, releasing neurotransmitters, and then
stimulating the next neuron. This applies to
motor functions such as muscle flexion in the
distal portion of fingers to stimulation of
hormone release resulting in trophic effects
throughout the body. TMS has applications
beyond motor tract modulation. The treatment of
depression is an example of neuro-modulation
that does not result in changes to any motor
networks.
Based on studies of how TMS evokes
electric potentials, it suggests that TMS
stimulates the axons of neurons rather than the
cell body itself. Accumulation of charge
surrounding the body of the neuron protects it
from stimulation. Axons have a lower threshold
needed for activation/ excitation as compared to
the neuron body. The electric fields produced by
magnetic stimulation then run parallel to the
tissue surface [15].

Different Forms of TMS
Repetitive TMS
There are varying forms of TMS that
can be utilized depending on the type and
intended outcome of treatment. The most
common form of TMS is repetitive TMS
(rTMS). rTMS is currently being used in the
treatment of depression. The figure-of-eight
coils generate a magnetic field creating a
stimulus that will last for a short period of time
ranging from milliseconds to several seconds
followed by intermittent periods of no
stimulation. This oscillation of stimulation to
rest repeats for the duration of the treatment and
results in excitation of the neurons in the
targeted portion of the brain [14, 16].
First developed in the mid-1980s,
repetitive TMS has been the most popular
stimulatory technique for treatment. With
constant refinement and specialization it is being
used to treat disorders such as depression,
psychosis, anxiety, bipolar disorders,
obsessions/ compulsions, PTSD; neurological
diseases like Parkinson’s and epilepsy; and
rehabilitation of motor function after stroke.
Many applications are still undergoing clinical
trials to test efficacy but are beyond proof of
principle [14, 17, 18].
Theta-Burst TMS
A more recent form of TMS being
researched is Theta-Burst Stimulation (TBS), a
form of TMS similar to rTMS but magnetic
pulses are applied in bursts of three at 50 Hz
with intervals of 200ms of 5 Hz between each
burst. One study measured the effects of three
types of TBS and the effects of motor evoked
potentials (MEPs) [19]. The first of the three
was intermittent TBS (iTBS), characterized by 2
seconds of theta-bursts repeated every 10
seconds for 190 seconds total resulting in 600
pulses being delivered. The second was
intermediate TBS (imTBS) where 5 seconds of
TBS signals were administered every 15 seconds
for 110 seconds again resulting in a total of 600
2

pulses being delivered. The third was continuous
TBS (cTBS) where a 40 second, uninterrupted
train of theta-bursts were delivered. Upon
completion of stimulus, changes in MEP
amplitude were measured for twenty minutes. A
single pulse of TMS over a motor tract above
motor threshold is used to evoke an
electromygraphy (EMG) response in small hand
muscles to measure the long-term potentiation
versus depression of the three TBS patterns.
There was a statistically significant difference
(p<0.005) in amplitude of MEP between each
pattern. imTBS failed to evoke significant
potentiation or depression of the MEP. cTBS
suppressed MEPs for the measured twentyminute interval after the treatment. Inversely,
iTBS facilitated MEPs for the measured time
frame post-application [19].
Based upon findings from increasing
numbers of studies on safety and efficacy of
TBS, reported symptoms and side effects are
comparable to or less than that of rTMS in both
frequency and severity [20]. A meta-analysis
study found that in 4,500 recorded sessions of
TBS one reported case of a seizure occurred
during treatment. Statistical risk of a seizure
associated with TBS is about 0.02%. This data is
equivocal with the statistical risk associated with
high frequency TMS. In the same meta-analysis
it was noted that adverse side effects of high
frequency TMS was around 40% while reported
adverse effects of TBS were less than 3% [21].
Low versus high frequency TMS
Repetitive TMS can have inhibitory or
excitatory effects depending upon the frequency
used. When the frequency of stimulation is low
(≤1 Hz) neuroinhibitory effects are observed.
TMS at 0.1 Hz fails to elicit any change in
cortical excitability but at 0.9 Hz, applied for 15
minutes, MEP amplitude was decreased by
nearly 20% and lasted for nearly 15 minutes
after treatment [22]. Other studies have found
that low-frequency rTMS can result in
significant suppression of MEPs that can persist
for 30 minutes, depressing motor excitability not

affecting basic motor behavior[23]. On the
inverse side of this, high-frequency rTMS can
lead to excitatory effects on MEP[24].
Further studies have been completed
comparing low versus high frequency rTMS and
the effects it has on cortical excitability. One
study comparing 1 and 20 Hz rTMS measured
the differences in cortical excitability. The
results were congruent with other studies, 1 Hz
resulted in decrease of cortical excitability while
20 Hz increased cortical excitability in all tested
subjects [25].
CURRENT APPLICATIONS:
Clinical Efficacy
With FDA approval of TMS for the
treatment of depression in 2008 [12] there have
been numerous studies done testing the safety
and efficacy. Currently, TMS is used in the
treatment of major depressive disorder (MDD), a
common form of depression characterized by
frequent, recurrent episodes that lead to
impairment and disability [26]. Standard
treatment methods for MDD are antidepressant
intervention but approximately 20-40% of
patients find no relief in symptoms from
medications and/ or psychotherapy [27]. It is not
uncommon for patients with MDD to develop a
treatment-resistant illness which ultimately leads
to a need for alternative treatment options. This
is where TMS has found its first role in clinical
settings.
The most commonly targeted cranial region for
TMS in the treatment of depression has been the
left and/ or right dorsolateral prefrontal cortex
(DLPFC), figure 2. It can be located by its
relative location to the motor area of the
abductor pollicis brevis [28]. Most trials choose
this region based on positive results from early
studies. Imaging studies also show that in
depressed patients there is decreased blood flow
to the left prefrontal cortex. After rTMS of this
area increased blood flow was observed [29].
Other studies have also applied low-frequency
rTMS to the right prefrontal cortex for the
3

inhibitory effects. It is theorized that opposing
sides of the brain have contrasting function over
mood and inhibition of the right prefrontal
cortex can achieve the same antidepressant
effects as high-frequency application over the
left prefrontal cortex [30-32].

figure 3. Remission rates were measured across
all three evaluation points with no statistical
difference being measured at two or four weeks
but a significant statistical difference being
measured at 6 weeks. No serious side effects
were observed during the study [33].

Figure 2. The blue shaded regions depict the dorsolateral
prefrontal cortex (DLPRC). The region most commonly
targeted by transcranial magnetic stimulation [32].

A study completed by (O’Reardon, et
al.) was aimed specifically at measuring safety
and efficacy of TMS over the left DLPFC as a
treatment for MDD, comprised of 301 diagnosed
MDD patients that did not benefit from prior
antidepressant treatments. All patients were
medication free and going through an MDD
episode of 3 years or less upon entering the
study. Severity of symptoms were measured on
the Clinical Global Impressions Severity of
Illness (CGI-S) score, the 17 and 24-item
Hamilton Depression Rating Scale (HAMD17),
and the Montogomery-Asberg Depression
Rating Scale (MADRS). The 301 patients were
evenly divided by random assignment between
two groups, one group set to receive the active
TMS treatment, while the other group received
sham treatment. Sham treatment exposes
participants to the same initial physical
procedures but the electrical current ceases after
the initial burst without the knowledge of the
patient [33].
Results were measured at two, four, and
six weeks. Positive changes were observed in
the active group when compared to the sham
group at the two-week interval. At four weeks
there was a statistical difference observed in the
MADRS (p=.038), HAMD17 (p=.006),
HAMD24 (p=.012), and CGI-S (p=.009) scores
favoring active TMS treatment. Trending
positive results of active treatment continued to
improve through the six-week evaluation point,

Figure 3. All figures are changes from baseline
scores during the acute treatment phase. (A) is
the change in Montgomery-Asberg Depreesion
Scale (MADRS). (B) Hamiliton Depression Rating
Scale (HAMD; 17 Item). (C) HAMD; 24 Item. [33]

A more recent study conducted by
(Nathan Bakker, et al. 2015) confirmed the
positive antidepressant effects of the O’Reardon
study, utilizing rTMS of the dorsomedial
prefrontal cortex (DMPFC) for major
depression. In this study, 98 patients underwent
DMPFC-rTMS. On the Beck Depression
Inventory-II scale, response/ remission rates
were 40.6%/29.2% respectively [14].
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Alternative Applications
Brain Mapping
One of the most recently FDA approved
applications of TMS has been the eXimia
navigated brain stimulation (NBS) system. This
device delivers biphasic TMS pulses used for
mapping motor cortices preoperatively to tumor
resections. Currently this is the only presurgical,
noninvasive method of stimulation mapping of
cortical function. The current gold standard for
mapping cortical function has been
intraoperative direct cortical stimulation (DCS)
during craniotomies. The advantage of the
current DCS method is that it allows for
localization of sub regions of the primary motor
cortex in relation to a tumor [34].
Preoperative evaluation using MRI of
patient motor cortices has been unsatisfactory
due to tumor-related variables. Peritumoral
edema, anatomical distortions, and changing
vasculature disrupt spatial resolution imaging
technology. New advances in TMS coupled with
three-dimensional magnetic resonance imaging
have produced new and promising brain
mapping capabilities. Navigated TMS (nTMS)
with optical stereotactic navigation is a feasible
method of mapping the peritumoral region of the
primary motor cortex.
Early nTMS systems were met with
varying levels of success which limited their
clinical applicability. More recently, a study
utilizing the combination of optically tracked
navigation with TMS was conducted. A main
advantage of the new system is its improved
accuracy being able to account for device
position, distance from cortex, and size and
shape of the patient’s head. In the study nTMS
method was used for preoperative mapping in 20
patients with brain tumors scheduled for tumor
resection. The goal of the study was to compare
accuracy of preoperative nTMS against the
current gold standard method of intraoperative
DCS. The eXimia NBS system was used to
calculate strength, location, and direction of
stimulatory electric fields in cortical tissue.

Manipulation of placement and orientation of
the nTMS device allowed for more accurate
mapping of primary motor cortex hotspots. This
method had a mean accuracy of 5.7mm [35].
Mapping of the tumor and peritumoral region
was performed at 110% of resting motor
threshold and 0.25 Hz. Stimulation to the tumor,
adjacent gyri and the tumor borders was
performed with increased special density and
further variation of coil rotation to ensure
maximally accurate topography. This whole
process can be completed in 30 minutes or less
and caused no discomfort for the patients.
Surgical planning and tumor resection
were performed by a surgeon separate from who
performed preoperative mapping. The operating
surgeon received no information about the
nTMS mapped “hotspots” but was informed of
motor function around the location of the tumor.
Intraoperative mapping was done by the surgeon
during surgery. The results of the intraoperative
mapping of the primary motor cortex “hotspots”
were imported to the same coordinate system
that was used with the nTMS. Images of
intraoperative DCS and nTMS were marked and
superimposed, figure 4. DCS and nTMS
mapping data was taken in 17/20 patients. Data
was not taken for 3 patients due to technical
errors or DCS not being performed due to
bleeding.
In all but one patient, hotspots were
located on the same gyrus. Mean distance
between the nTMS hotspots and the DCS
hotspots was 7.83± 1.18mm for the motor cortex
of the abductor pollicis brevis muscle and
7.07±0.88mm for tibialis anterior muscle. A
strong negative correlation was observed
between the number of DCS responses and the
distance between the nTMS and DCS hotspots.
More DCS stimulations resulted in more
accurate hotspot mapping and decreased the
distance between nTMS and DCS to less than
5mm mean distance difference.
Advantages of TMS are that it is a
timelier and equally thorough tool for examining
5

only performed in a select subset of patients, has
been highly reliable and a vast amount of
information on the variability of cortical
language representation has been gathered. The
only other preoperative language mapping
technique that has been previously utilized has
been functional magnetic resonance imagining
(fMRI), however the accuracy of this technique
has proven to be less than desirable. Since fMRI
is reliant on blood flow to regions for mapping,
lesions like gliomas can hamper the accuracy by
inducing edema and change oxygenation in the
peritumoral region [37].

Figure 4. Comparison of nTMS hotspots mapped
against DCS hotspots for abductor pollicis brevis
muscle. Red points mark the nTMS hotspots while
the orange represents the DCS hotspots [35].

motor topography compared to DCS. TMS also
allows for cortical mapping in patients who are
not suitable for functional MRI techniques. TMS
is best utilized for preoperative diagnostics of
motor function and its accuracy are comparable
to current gold standards [35].
Robotic TMS is another emerging
technique for brain mapping. Similar to nTMS,
it allows for reliable and accurate detection of
the represented motor cortexes for individual
muscles or muscle groups. An advantage of this
method is that it can be used to detect brain
regions that are displaced due to tumor
formation [36].
In addition to the mapping of motor
regions, TMS can also be used in mapping
speech centers of the brain. Patients with lesions
of language centers of the brain were scheduled
for surgical excision and received mappings via
nTMS and traditional intraoperative DCS. The
current method of intraoperative mapping,
which utilizes an awake surgery approach and is

Results from the Tarapore, et al. 2016
study on preoperative brain mapping of
language centers using nTMS demonstrated
TMS as effective as current DCS methods.
Advantages associated with preoperative nTMS
also include improved risk-benefit assessment
and extend of risk for lesion resection. nTMS
also benefits patients not suitable for awake
craniotomies, creating safer surgeries with
alternatives to intraoperative mapping
techniques. Preoperative mapping also creates
possibility for smaller, more targeted
craniotomies and faster intraoperative mapping.
Navigated TMS was well tolerated with no
adverse events reported, demonstrating
superiority to intraoperative DCS, which can
elicit seizures during the craniotomies. All
patients that would be subject to awake
craniotomies can complete noninvasive
language center mapping helping to tailor the
craniotomy size, location, and resection
trajectory. Results from preoperative nTMS
should still be confirmed with intraoperative
DCS [38].
Stroke Recovery
Improvements in medicine have greatly
increased the survival rates in patients post
stroke. Upwards of 70% of patients who survive
still experience motor impairment one year after
incidence[39]. Patients who have suffered from
strokes currently have several treatment options
available to them. Most of these treatments
6

involve the retraining or stimulation of the
muscles on the affected side of the body.
Bilateral movement training and constraintinduced movement therapy are two treatment
methods that work to physically retrain muscle
function and are best utilized as close to the
stroke incident as possible[40],[41]. Other
rehabilitation methods involve brain stimulation,
improving upon neuro-plasticity.
Neuromodulation with TMS or
transcranial direct current stimulation (TDCS)
are emerging as methods with proof of principle
benefits in upregulating the excitability in the
lesioned hemisphere or downregulating
excitability in the intact hemisphere[42]. TMS,
as a non-invasive technique, can be used in
conjunction with our rehabilitation techniques
and can enhance the effects of training and
performance motor tasks. These motor tasks can
include daily tasks which can allow for patients
to better care for themselves and regain
functions that would previously have been
impaired[43].
Memory Enhancement
A new and rather exciting possible
application for TMS is in memory enhancement
and presentation of savant like-skills. Savants
are commonly associated with individuals with
autism, specifically Asperger Syndrome, but
these skills have also been observed post
traumatic brain injury or encephalitis. It has
been hypothesized that the skills and abilities
needed to be able to process information like
savants are present in everyone but lie dormant
from chronically processing information
differently.
The cause for presentation of these skills
is still unknown but research is being done to see
if these traits can be artificially triggered in
people who don’t otherwise display exceptional
talents. Snyder A, et al. 2003 performed small
scale, sham controlled, study was done using
rTMS to inhibit neural activity of the cerebral
cortex in the left anterior temporal lobe and
savant-skills were artificially produced [44].

During the study a subset of the
participants saw significant improvement in
drawing ability, proofreading, and numerosity.
All results were compared to pre-treatment
baselines and then recorded during and
immediately after treatment. All instances of
induced, savant characteristics diminished over
time, returning to baseline within an hour after
completion of rTMS application. No induced
changes were observed in participants who
received sham stimulation [44].
Associated Risks
Most patients experienced little to no
serious side effects associated with TMS. The
most commonly reported side effects, according
to multiple clinical studies evaluating the
efficacy and safety of TMS, was tingling or
scalp discomfort around the area of application.
Seizures are listed as a possible side effect
however multiple large-scale studies have shown
that the risk is rather insignificant. Since the
updated safety guidelines in 1998, there have
been four reported cases of seizures, three of
which the patients also took medications that
could increase the likelihood of seizures and the
fourth may have been a non-epileptic event [16]
Patients with cochlear implants,
aneurysm clips, bullet fragments, or any other
form of conductive metal objects inserted in
their brain and are non-removeable or within
30cm should avoid magnetic stimulation. There
is an obvious risk in these cases that the
magnetic fields generated by the coils can either
disrupt the function of these devices or cause
displacement resulting in serious injury or death
[16].
Short-Term Side Effects
According to several studies completed,
most side effects associated with TMS are short
lasting and quickly dissipate with the completion
of treatment sessions, rarely lasting longer than
the hour following treatment. As previously
mentioned, the most commonly reported side
effects are mild scalp discomfort at the site of
7

application, headaches, and neck pain that
alleviate immediately after application ceases
[45].
Long-Term Side Effects
Studies that have considered potential
long-term effects have largely been
inconclusive. There has also been a lack of
recorded follow up with patients after the
treatment period ceases. Alterations in
neuroplasticity are theorized to be the most
significant long-term side effect. A common
concern is the potential negative effect of
repetitive electric stimulation on neural tissue. In
a 1990 study by Gordon, et al., two epileptic
patients received stimulation up to 50 Hz to the
anterior temporal lobe for a period, and then the
temporal lobes were resected from the patients
and studied for histological damage. Using lightmicroscopy, no damage was observed [46, 47].
Previously mentioned was the concern
of effects on neuroplasticity. The concern is
electrical stimulus by TMS and the long-term
potentiation (LTP) generated. This is where the
repetitive nature of electrical brain stimulation at
high frequencies can lead to lasting
physiological changes in behavior conditioning.
For a patient suffering from MDD and receiving
TMS treatment, the desired effect is to alter
neural function and induce lasting changes that
will alleviate associated symptoms [48].
The lack of conclusive evidence to any
negative long-term side effects of repeated
electrical stimulation should be taken as positive
sign for the possibility of further application of
TMS but should not be taken as final. There are
still a lot of questions that need to be answered
about the effects of stimulation on
neuroplasticity and what changes it could have
years down the line. Further research into long
term effects of varying TMS treatments should
be a source of interest and discussion if TMS is
to be an effectively wide spread source of
treatment.
CONCLUSION:

Limitations
While TMS has been shown to be a safe
and effective form of treatment for depression as
well as useful tool in brain mapping there are
still extensive limitations. Current TMS methods
are only able to effectively target regions on the
outermost layer of the brain. While the scalp is
easily permeable to the magnetic fields, the
intensity of the magnetic fields is greatly
reduced beyond just a few centimeters. The
regions of the brain that are most easily targeted
by TMS lie in the cortical mantle of the brain,
within 2-3cm of the surface [49]. New and novel
techniques and improvement in coil technology
are being produced and tested to target deeper
regions of the brain, but current methods are
limited to the outer cranial regions. The area that
the magnetic field can induce and provoke
change in is also relatively small, a spatial
resolution of 0.5-1cm. This limits the ability to
study contributions of structures such as cortical
columns [50].
Other limitations of TMS are largely
associated with the side effects of the treatment.
There have been international guidelines [16] set
in place that outline parameters for treatment
frequency and intensity. Treatment within these
guidelines is proven to be safe and effective but
not without risk. Seizures and syncope are the
two most serious side effects reported but
improvements in treatment protocol is resulting
in fewer reported incidences. Sensory side
effects are among the most commonly reported,
unintended consequences of treatment. These
include tapping sensations and/ or auditory
clicks. These sensory side effects are results
from the rapid change of magnetic fields that
TMS generates. In studies measuring
somatosensory or auditory effects these can
influence and interfere with task performance
and results [51]. Depending on the location of
the treatment the intensity of sensory effects can
change, increased auditory clicking being
associated with treatment being closer to the
auditory region of the brain, lessening as
treatment gets further away and similar results
8

for somatosensory effects. More minor side
effects such as headaches, neck pain, and scalp
irritations ranging from mild to moderate are
associated with TMS and can impact the results
of studies and treatment due to patients wishes
to cease treatment.
Currently in the United States, the FDA
has approved the use of TMS for only a small
number of psychiatric and neurological
applications. Two TMS devices have been
approved for the use of treating depression and
depression related symptoms. In neurological
applications, Nexstim eXimia Navigated Brain
System TMS has been approved for brain
mapping [27].
Further research
While these applications of TMS are
being widely implemented in clinics across the
country there are still relatively new and novel
techniques and just begin to scratch the surface
of what future applications could be instore.
Many possible applications are still in the proof
of principle phase or even unknown. Extensive
research has been done on the safety and
efficacy of noninvasive stimulatory treatments
for depression and brain mapping, however,
there has been far less research on other
applications. A search into possible uses for
TMS yields numerous results that range from
treatment of psychological disorders like
obsessive-compulsive disorder (OCD) and
addiction. Other possibilities include
applications to better understand
interconnectedness of neuronal pathways. Most
studies that have been done or are currently
being conducted measuring the effectiveness of
TMS for uses beyond what has been discussed
are mostly still in the proof of principle stage,
being conducted with small numbers of

individuals taking part and no control or sham
groups to compare against.
Areas of research that are gaining
popularity are related to the use of TMS
techniques in the treatment of psychological
disorders. Small scale studies have been done
testing the efficacy of low-and high- frequency
rTMS over varying cerebral regions to depress
obsessive-compulsive symptoms. Since OCD
has been characterized by hypermetabolism of
orbitofrontal-striatal circuits, using depolarizing
magnetic fields can help in decreasing
symptoms and returning neural function to a
normalized level. In studies that include doubleblinded sham control groups, no advantage was
found in active treatment over sham treatment.
Further research is needed here that accounts for
careful consideration of regions to target and
stimulate parameters. Novel stimulation methods
are also needed, considering the potential effect
inhibitory or depressive effect that theta-burst
stimulation could have on OCD associated
pathways. Other possible uses of TMS, and
specifically rTMS, as it relates to OCD may
include modulation of obsessive-compulsive
symptoms so that brain activity could be
measured with functional magnetic resonance
imaging and receptor-binding studies[52].
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APPENDICIES:
A. Citations for this review were done using NLM formating.
B. Feeback received from my reviewer, Dr. Chrisophter Bilbao D.O., included information on a
push in the medical industry for well developed, minimally invasive procedures. The goals of
these being to lessen the length of stay and cost for patients. Other information provided was
insight into current methods of mapping brain tumors and how tumor-related variables can
complicate this. Other beneficial feedback included better formatting and organizational
techniques for the review as a whole and encouragement to clarify or better explain certain topcis.
I gladly accepted the feedback received and used it to help guide the review.
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